Study to Evaluate the Safety and Activity of TTX030 (Anti-CD39) in Combination with Budigalimab and/or Chemotherapy in Subjects with Advanced Solid Tumors (TTX-030-002)
Study to Evaluate the Safety and Activity of TTX030 (Anti-CD39) in Combination with Budigalimab and/or Chemotherapy in Subjects with Advanced Solid Tumors (TTX-030-002)
Trial Category:
Genitourinary
Phase
I
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
